What is the recommended treatment for peritonitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Treatment of Peritonitis

For peritonitis, immediate surgical source control combined with broad-spectrum intraperitoneal antibiotics (glycopeptide plus third-generation cephalosporin or aminoglycoside) represents the standard of care, with emergency laparotomy required for diffuse peritonitis as soon as possible, even while resuscitation continues.

Immediate Management Algorithm

1. Resuscitation and Stabilization

  • Begin rapid intravenous fluid resuscitation immediately upon diagnosis 1
  • For septic shock, start resuscitation the moment hypotension is identified 1
  • Continue physiologic stabilization measures even during emergency surgery if needed 1

2. Antibiotic Therapy Timing and Selection

Initiate antibiotics immediately when peritonitis is diagnosed or strongly suspected 1:

For Community-Acquired Peritonitis:

  • Mild-to-moderate severity: Single agents like cefoxitin, amoxicillin-clavulanate plus gentamicin, or piperacillin-tazobactam 1, 2
  • High severity/septic shock: Broader coverage required 1

For Healthcare-Associated/Nosocomial Peritonitis:

  • Imipenem plus amikacin as reference treatment 2
  • Add empiric antifungal coverage (fluconazole) until culture results available 2
  • Higher likelihood of multidrug-resistant organisms requires broader initial coverage 3

For Peritoneal Dialysis-Associated Peritonitis:

  • Intraperitoneal route is superior to intravenous 4, 5
  • Glycopeptide-based regimens (vancomycin or teicoplanin) achieve higher complete cure rates compared to first-generation cephalosporins 4
  • Empirical coverage must include both Gram-positive (vancomycin or cefazolin) and Gram-negative organisms (third-generation cephalosporin or aminoglycoside) 6, 7
  • Target peritonitis rate: ≤0.40 episodes per year at risk 6

3. Source Control - The Critical Determinant

Patients with diffuse peritonitis require emergency surgical intervention immediately 1:

  • Do not delay surgery for imaging if diffuse peritonitis is clinically obvious 1
  • Drain infected foci, control ongoing contamination, and restore anatomy 1
  • For localized abscesses in hemodynamically stable patients, percutaneous drainage is preferable to surgery 1

Surgical Approach:

  • Emergency laparotomy: For diffuse peritonitis, proceed immediately even if resuscitation ongoing 1
  • Damage control surgery: In life-threatening situations, prioritize stability over definitive repair 3
  • Urgent approach (within 24 hours): For stable patients without organ failure, may delay if appropriate antibiotics given and close monitoring provided 1

Catheter Management (PD-Associated):

  • Simultaneous catheter removal and replacement superior to urokinase for relapsing/persistent peritonitis 4
  • Catheter removal may be optimal for treatment failures 4

4. Antibiotic Administration Details

Key principles:

  • Maintain satisfactory drug levels during source control procedures; may require additional dosing before surgery 1
  • Continuous versus intermittent dosing: Both schedules show similar efficacy 4
  • Duration typically ranges from 48 hours (less severe) to 14 days (severe cases) 2
  • For PD peritonitis, 21-day courses show uncertain benefit over 10 days but may increase ototoxicity 4

5. Microbiologic Considerations

  • Blood cultures not routinely recommended for community-acquired infections 1
  • Exception: Obtain blood cultures if patient appears toxic or immunocompromised 1
  • Gram stain of infected material has no proven value for community-acquired infections 1
  • Monitor local antibiogram: Microbiology patterns change over time, with some centers reporting increased ESBL organisms 7

Common Pitfalls to Avoid

  1. Delaying surgery for imaging: If diffuse peritonitis is clinically evident, proceed directly to operating room 1
  2. Inadequate initial antibiotic coverage: Must cover both aerobes (E. coli) and anaerobes (B. fragilis) 2
  3. Ignoring Enterococcus: Consider coverage in organ failure or septic shock 2
  4. Wrong antibiotic route for PD peritonitis: Intraperitoneal administration is superior 4, 5
  5. Mandatory relaparotomy: Not recommended in severe peritonitis unless specific indications present (intestinal discontinuity, fascial loss, intra-abdominal hypertension) 1

Special Populations

Highly selected patients with minimal physiological derangement and well-circumscribed infection (periappendiceal/pericolonic phlegmon) may receive antibiotics alone without source control, but only with very close clinical follow-up 1. This is the exception, not the rule.

Immunocompromised or obtunded patients: Maintain high index of suspicion for intra-abdominal infection even with unreliable examination findings 1.

References

2
Research

[Therapeutic management of peritonitis].

Medecine et maladies infectieuses, 2004

4
Research

Treatment for peritoneal dialysis-associated peritonitis.

The Cochrane database of systematic reviews, 2014

5
Research

How should peritoneal-dialysis-associated peritonitis be treated?

Nature clinical practice. Nephrology, 2008

6
Research

ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 2022

Related Questions

For a US paramedic, what is the complete EMS management and treatment protocol for peritonitis from the initial call through transport—including specific medications, dosages, and administration timing—and, if the peritonitis is chronic, which medications might the patient already be taking, their mechanisms, and the complications of delayed treatment?
What is the recommended treatment for Staphylococcus aureus peritoneal dialysis-associated peritonitis?
What are the KDIGO diagnostic criteria for continuous ambulatory peritoneal dialysis (CAPD) peritonitis and what is the recommended treatment?
What is the drug of choice for empiric therapy of peritonitis in an adult patient without known drug allergies or severe renal impairment?
Should intravenous total parenteral nutrition be administered in a patient with peritonitis?
How can consuming seven cups of coffee daily cause chronic maintenance insomnia in a 50‑year‑old woman?
Is propranolol (a beta‑blocker) appropriate for a 14‑year‑old adolescent with social anxiety?
How should leukocytosis be evaluated and managed?
What is the appropriate evaluation and management for a patient with a one‑week history of dizziness and a 19 mmHg systolic blood pressure difference between the right and left arms, with otherwise normal bilateral blood pressures?
In a 40-year-old woman with progressive dyspnea, a 20‑pack‑year smoking history, normal vital signs, diffuse thin‑walled cysts on chest CT including the costophrenic angles, a renal angiomyolipoma, negative serology for connective tissue disease, and a serum vascular endothelial growth factor‑D level of 1200 pg/mL, what is the most likely diagnosis?
What is the association between vulvar problems and ankylosing spondylitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.